ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 19 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,000 | -16.0% | 3,473 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $25,000 | -13.8% | 3,473 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $29,000 | +26.1% | 3,473 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $23,000 | -23.3% | 3,473 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $30,000 | +57.9% | 3,473 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $19,000 | -5.0% | 3,473 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $20,000 | -9.1% | 3,473 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $22,000 | +37.5% | 3,473 | 0.0% | 0.00% | +50.0% |
| Q4 2014 | $16,000 | -42.9% | 3,473 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $28,000 | -15.2% | 3,473 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $33,000 | -19.5% | 3,473 | 0.0% | 0.01% | -25.0% |
| Q1 2014 | $41,000 | -24.1% | 3,473 | 0.0% | 0.01% | -27.3% |
| Q4 2013 | $54,000 | +145.5% | 3,473 | 0.0% | 0.01% | +120.0% |
| Q3 2013 | $22,000 | -21.4% | 3,473 | 0.0% | 0.01% | -37.5% |
| Q2 2013 | $28,000 | – | 3,473 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 290,501 | $2,513,000 | 1.83% |
| Knoll Capital Management, LLC | 20,000 | $173,000 | 0.11% |
| Private Portfolio Partners LLC | 42,250 | $365,463 | 0.09% |
| Rossmore Private Capital | 40,661 | $352,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 54,233 | $469,000 | 0.04% |
| Cubist Systematic Strategies, LLC | 241,892 | $2,092,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 662,000 | $5,726,000 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 550,956 | $4,766,000 | 0.01% |
| Jump Financial, LLC | 34,800 | $301,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 264,824 | $2,291,000 | 0.01% |